MedElevator Войти в исследования
← Поиск публикаций

DOI 10.31557/apjcp.2026.27.5.1873

Медицинская библиотека · Asian Pacific journal of cancer prevention : APJCP · 2026

Sesamin Mitigates Gastric Carcinogenesis via Modulation of the PI3K/AKT/mTOR Signaling Pathway in AGS Cells and MNNG-Induced Rats.

Parthiban Manju, Rajagopal Ponnulakshmi, Maheswari Jayaveeran Heera, Jayaraman Selvaraj, C Krithika, Varalakshmi V Sureka

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Gastric cancer (GC) is a leading cause of cancer-related death worldwide, frequently associated with dysregulated PI3K/AKT/mTOR signaling and defective apoptosis. Sesamin, a lignan from sesame seeds, is rich in antioxidant and anticancer activities, yet it has not been well investigated for its therapeutic potential in GC.

OBJECTIVE

This study aims to investigate the anticancer potential of sesamin against gastric cancer by targeting the PI3K/AKT/mTOR signaling pathway in AGS cells and MNNG-induced rats, evaluating its effects on apoptosis, oxidative stress, and tumor biomarkers to elucidate its molecular mechanism of action.

METHODS

In vitro, molecular changes in AGS gastric cancer (GC) cells were determined by RT-PCR (p53, caspase-3, MDM2, PTEN, AKT, mTOR, NF-κB). In vivo, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) was used to induce gastric cancer in Wistar rats. The intervention of sesamin was studied by histopathological analysis, and ELISA was used for the measurement of tumor markers (CEA and CA 19-9) and oxidative stress markers. Gene expression was analyzed by RT-PCR (p53, caspase-3, AKT, NF-κB, mTOR).

RESULTS

Sesamin treatment in AGS cells upregulated PTEN, p53, and caspase-3, while downregulating MDM2, AKT, mTOR, and NF-κB at the mRNA level in the in vitro study. In the in vivo mRNA expression analysis, sesamin treatment confirmed enhanced p53 and caspase-3 with reduced AKT expression and slightly increased mTOR expression. In MNNG-induced rats, sesamin improved gastric histology, decreased tumor markers (CEA, CA 19-9), suppressed IL-1β, and elevated GSH. RT-PCR analysis further validated the induction of pro-apoptotic genes and suppression of oncogenic PI3K/AKT/mTOR/NF-κB signaling, consistent with in vitro findings.

CONCLUSION

Sesamin has demonstrated effective anti-gastric cancer activity by inducing p53/caspase-3-mediated apoptosis and inhibiting the PI3K/AKT/mTOR/NF-κB signaling pathway. These findings illustrate the therapeutic potential of sesamin against gastric cancer and reveal molecular clues for its use as a natural chemopreventive agent.

Для цитирования: Parthiban Manju, Rajagopal Ponnulakshmi, Maheswari Jayaveeran Heera, Jayaraman Selvaraj, C Krithika, Varalakshmi V Sureka. Sesamin Mitigates Gastric Carcinogenesis via Modulation of the PI3K/AKT/mTOR Signaling Pathway in AGS Cells and MNNG-Induced Rats.. Asian Pacific journal of cancer prevention : APJCP. 2026. DOI: 10.31557/apjcp.2026.27.5.1873.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.